Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease
Clinical trial NCT05854615 · RECRUITING
Trial details
- NCT number
- NCT05854615
- Sponsor
- Cell Biopeutics Resources Sdn Bhd
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2027-10-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.